CATALOGO DEI PRODOTTI DELLA RICERCA

IDOLAZZI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.025
NA - Nord America 4.529
AS - Asia 1.980
SA - Sud America 23
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 11.585
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.509
GB - Regno Unito 2.029
CN - Cina 1.485
IT - Italia 509
DE - Germania 506
SE - Svezia 471
IE - Irlanda 389
FR - Francia 382
RU - Federazione Russa 332
SG - Singapore 292
FI - Finlandia 228
UA - Ucraina 74
TR - Turchia 65
JP - Giappone 58
BE - Belgio 28
VN - Vietnam 25
NL - Olanda 17
CA - Canada 16
KR - Corea 15
RO - Romania 15
AT - Austria 12
BR - Brasile 12
IR - Iran 11
IN - India 6
AU - Australia 5
CH - Svizzera 5
QA - Qatar 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EG - Egitto 4
EU - Europa 4
HK - Hong Kong 4
TG - Togo 4
AR - Argentina 3
CL - Cile 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PL - Polonia 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EC - Ecuador 2
ES - Italia 2
HR - Croazia 2
KG - Kirghizistan 2
SA - Arabia Saudita 2
SI - Slovenia 2
ZA - Sudafrica 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 11.585
Salva come PNG Salva come JPEG
Città #
Southend 1.927
Chandler 956
Jacksonville 469
Woodbridge 390
Dublin 388
Ann Arbor 315
Ashburn 290
Beijing 250
Houston 205
Singapore 195
Lawrence 161
Princeton 161
Wilmington 155
Jinan 144
Redmond 128
Shenyang 126
Bologna 124
Nanjing 120
Verona 94
Helsinki 84
New York 83
Hebei 73
Tianjin 63
Tokyo 53
Zhengzhou 52
Changsha 51
Haikou 51
Ningbo 51
Sindelfingen 44
Taizhou 41
Nanchang 38
Taiyuan 38
Milan 35
Redwood City 34
Hangzhou 31
Jiaxing 31
Brussels 25
Norwalk 25
Guangzhou 24
Lanzhou 24
Boardman 23
Fuzhou 23
Washington 22
Düsseldorf 21
Los Angeles 20
Seattle 20
Dearborn 19
Sanayi 18
Dallas 16
Lancaster 16
Falls Church 15
Nürnberg 15
Orani 15
Fairfield 13
San Francisco 13
Detroit 12
Dong Ket 11
Venice 11
Vienna 11
Chicago 10
Toronto 10
Esslingen am Neckar 9
Florianópolis 8
Bârlad 7
Dongguan 7
Rome 7
Seoul 7
Cagliari 6
Clearwater 6
Denver 6
Kemerovo 6
Kent 6
Seo-gu 6
Auburn Hills 5
London 5
Moscow 5
Turin 5
Central 4
Easton 4
Lomé 4
Munich 4
Renton 4
Riva 4
Shanghai 4
Zanjan 4
Amsterdam 3
Ardabil 3
Biandronno 3
Brescia 3
Frankfurt am Main 3
Genova 3
Luino 3
Novokuznetsk 3
Phoenix 3
Romola 3
San Mateo 3
Santa Clara 3
Tappahannock 3
Tarcento 3
Trieste 3
Totale 8.061
Salva come PNG Salva come JPEG
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 246
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 148
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 131
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 130
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 122
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 117
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 116
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 115
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 115
DXA bone mineral density in males: retrospective study in real life. 113
Prevalence and incidence of rheumatoid arthritis in Italy. 113
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 111
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 111
Bone metabolism in patients with anorexia nervosa and amenorrhoea 111
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 109
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 108
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 108
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 107
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 104
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 104
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 103
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 102
Osteopetrosi 102
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 102
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 102
Prevalence of osteoporosis in patients affected by mastocytosis 100
Vitamin D levels in patients with psoriasis with or without arthritis 98
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 98
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 97
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 97
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 97
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 96
Could γ\δ T-cells explain zoledronic acid adverse events? 95
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 95
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 93
Periostin: The bone and beyond 92
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 91
MEDAL con etoricoxib: l’inizio di una nuova era per il trattamento del dolore muscolo scheletrico 90
Bone involvement and osteoporosis in mastocytosis. 90
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 88
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 88
Drug-induced osteonecrosis of the jaw: the state of the art 88
Duration of treatment for osteoporosis 88
Bone involvement in patient with clonal mast cell disorders 87
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 87
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 87
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 86
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 86
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 86
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 86
Effects of denosumab on peripheral lymphocyte subpopulations 86
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 85
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 85
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 84
Sclerostin and DKK1 in primary hyperparathyroidism. 84
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 83
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 83
Osteoporosi ed attività sportiva. 82
Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. 82
Rheumatoid arthritis, γδ T cells and bisphosphonates 82
Variazione della densità minerale ossea ed attività antifratturativa; 82
Vitamin D and rheumatic diseases. 81
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 81
Osteoporosi ed attività sportiva: 80
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 80
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 80
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 77
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 77
Ruolo della vitamina D 76
Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. 76
Neridronic acid for the treatment of bone metabolic diseases 76
Seasonal and regional variations in the prevalence of vitamin D insufficiency in patiens with theumatoid arthritis 76
The obesity paradox and osteoporosis 76
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 75
Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight 74
Variazione della densità minerale ossea ed attività antifratturativa. 73
The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1 73
Disease activity and left ventricular systolic function in rheumatoid arthritis 72
Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis 72
Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study 72
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 71
Focal bone involvement in inflammatory arthritis: the role of IL17 71
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 71
Effects of secukinumab on serum adipocytokines: preliminary data 70
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 69
Clinical development of neridronate: potential for new applications. 69
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 69
Vitamin D status in patients with chronic plaque psoriasis 68
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 68
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 68
Vitamin D: not just bone, but also immunity 67
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 67
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 67
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 67
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 66
Concept of Remission in Chronic Plaque Psoriasis 63
Development and First Validation of a Disease Activity Score for Gout 63
Could nail and joint alterations make the difference between psoriatic arthritis and osteoarthritis during the ultrasonographic evaluation of the distal interphalangeal joints? 63
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 63
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 63
Totale 8.944
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.557
article - articoli 40.982
book - libri 0
conference - conferenze 339
curatela - curatele 0
other - altro 236
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.104 0 0 0 138 153 141 152 86 95 98 79 162
2020/20211.377 188 285 40 255 182 122 20 43 81 11 107 43
2021/20221.208 93 347 7 62 54 29 24 65 81 24 85 337
2022/20232.716 192 292 244 501 215 654 45 145 295 30 76 27
2023/20241.266 54 115 109 153 159 184 61 126 6 37 190 72
2024/2025631 153 221 152 105 0 0 0 0 0 0 0 0
Totale 11.898